Wednesday, July 29, 2020 1:10:12 PM
1. There will be some kind of signficant news at tomorrow's meeting. It seems there is significant support on this board and others for the idea that CYDY announced a call with the Nader, Dr. Kelly, Dr. Lalezari to tell us "we will hear more in just a few days or weeks." That seems very unlikely. Nader has done things in the past that have defied explanation but I don't think that will happen this time. There were many that felt we wouldn't get a safety look into CD12 or get more analysis of CD10 until August. Nader had a little more time if he needed it, but he called this meeting and I believe he called it because they have something to share. (Could be good, could be bad)
2. Are they going to share bad news about how Leronlimab performed in these trials? Here is what I know. Nader drives me crazy. Nader may be in over his head as CEO of a $3 Billion biotech BUT, Leronlimab has not disappointed us yet. It is a jewel. In all the thousands of attacks on CYDY, on Nader, I have yet to read anything or see any evidence that states that Leronlimab is anything less than an amazing treasure of science. Sure some "hard-working" shorts say "it doesn't work" or it's a fraud but I've yet to read a single sincere post that has successfully questioned the science. Not a single one. So I believe we are going to get data tomorrow and it won't be time for Nader to speak(although he will) but the main speaker tomorrow is Leronlimab and Leronlimab has yet to disappoint us.
3. There will not be a PR of data prior to the call. If the data is what I think it is, Nader is going to want to enjoy his home run trot. We all know the setup speech we are going to hear tomorrow prior to the data. I hate it. Makes me uncomfortable. But when Nader turns the mic over to Leronlimab that is when the real talking begins.
Just a few more hours to place your bet. As for me, I will continue to place my money on Leronlimab.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM